Journey Medical Corp (DERM)
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Journey Medical Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 28.22M shares outstanding
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
Leadership
Claude Maraoui
Founder, President, Chief Executive Officer & Director
Justin Smith
Director
Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board of Directors
Michael Pearce
Director
Employees
58
Country
US
Sector
Healthcare
Website
journeymedicalcorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 50.0K | -- | Jul 1, 2026 | |
| Director | Grant/Award | 50.0K | -- | Jul 1, 2026 | |
| Director | Grant/Award | 50.0K | -- | Jul 1, 2026 | |
| Director | Grant/Award | 10.0K | -- | Jun 25, 2026 | |
| Director | Grant/Award | 10.0K | -- | Jun 25, 2026 | |
| Director | Grant/Award | 10.0K | -- | Jun 25, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Wasatch Advisors LP · also on 13F· may incl. warrants· filed Oct 2026 | 2.4M | 8.7% | 13G |
WASATCH ADVISORS LP | 2.4M | 8.7% | 13F |
Maraoui Claude President & CEO, Director | 2.4M | 8.6% | FORM 4 |
TANG CAPITAL MANAGEMENT LLC | 1.6M | 5.7% | 13F |
Vanguard Capital Management · also on 13F· may incl. warrants· filed Jul 2026 | 774.6K | 2.7% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 675.2K | 2.4% | 13F |
Alloush Ramsey Chief Operating Officer | 598.5K | 2.1% | FORM 4 |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 536.0K | 1.9% | 13F |
Pale Fire Capital SE | 528.6K | 1.9% | 13F |
Opaleye Management Inc. | 350.0K | 1.2% | 13F |
Insiders
- Smith Justin AdamDirector
- Herskowitz NeilDirector
- Toledano Miranda JayneDirector
- ROSENWALD LINDSAY A MDDirector
- Pearce Michael CooperDirector
- Benesch JosephCFO
- Alloush RamseyChief Operating Officer
- Maraoui ClaudePresident & CEO
based on 28.22M shares outstanding
30d Avg
186.44K
60d Avg
183.07K
90d Avg
195.81K